Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity

v3.22.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Restatement adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Restatement adjustment
Accumulated Deficit
Accumulated Deficit
Restatement adjustment
Accumulated Other Comprehensive Income
Beginning balance at Dec. 31, 2020 $ 308,846 $ (8,139) $ 4 $ 325,679 $ (7,062) $ (25,442) $ (1,077) $ 8,605
Beginning balance (in shares) at Dec. 31, 2020     38,426,669          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Transfer of Private Warrants to Public Warrants 2,502     2,502        
Net income (loss) (12,025)         (12,025)    
Other comprehensive loss, net of tax (2,038)             (2,038)
Stock-based compensation 1,639     1,639        
Ending balance at Mar. 31, 2021 290,785   $ 4 322,758   (38,544)   6,567
Ending balance (in shares) at Mar. 31, 2021     38,426,669          
Beginning balance at Dec. 31, 2021 313,871   $ 4 330,616   (26,436)   9,687
Beginning balance (in shares) at Dec. 31, 2021     38,871,646          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Transfer of Private Warrants to Public Warrants 605     605        
Net income (loss) 2,726         2,726    
Other comprehensive loss, net of tax (2,227)             (2,227)
Stock-based compensation 1,354     1,354        
Net share settlements of stock-based awards (291)     (291)        
Net share settlements of stock-based awards (in shares)     146,444          
Shares issued for payment of contingent consideration 23,936     23,936        
Shares issued for contingent consideration (in shares)     2,659,574          
Ending balance at Mar. 31, 2022 $ 339,974   $ 4 $ 356,220   $ (23,710)   $ 7,460
Ending balance (in shares) at Mar. 31, 2022     41,677,664